Actinomycins with altered threonine units in the β-peptidolactone

Journal of Natural Products

Volumn 69, Issue 8, 2006, Pages 1153-1157

  Bitzer, Jens ^a   Gesheva, Victoria ^b   Zeeck, Axel ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOMYCIN G5; BETA PEPTIDOLACTONE; DACTINOMYCIN; LACTONE DERIVATIVE; THREONINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOSYNTHESIS; CYTOTOXICITY; DRUG STRUCTURE; SPECTROSCOPY; STREPTOMYCES; STRUCTURE ACTIVITY RELATION;

BACILLUS SUBTILIS; CANDIDA ALBICANS; CITRUS SINENSIS; DACTINOMYCIN; DRUG SCREENING ASSAYS, ANTITUMOR; ESCHERICHIA COLI; HUMANS; ISRAEL; LACTONES; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; STAPHYLOCOCCUS AUREUS; STEREOISOMERISM; STREPTOMYCES; STRUCTURE-ACTIVITY RELATIONSHIP; THREONINE; TUMOR CELLS, CULTURED;

STREPTOMYCES IAKYRUS;

EID: 33748760941     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np060063g     Document Type: Article

References (28)

1. Mauger, A. B.; Lackner, H. In Anticancer Agents from Natural Products; Kingston, D. G. I., Cragg, G. M., Newman, D. J., Eds.; CRC Press: Boca Raton, 2005; pp 281-298.
2. Brockmann, H. Angew. Chem. 1960, 24, 939-947.
3. Farber, S.; D'Anagio, G.; Evans, A.; Mitus, A. J. Urol. 2002, 168, 2560-2562.
4. Kamitori, S.; Takusagawa, F. J. Am. Chem. Soc. 1994, 116, 4154-4165.
5. Lackner, H. Angew. Chem. 1975, 87, 400-411;
6. Angew. Chem., Int Ed. 1975, 14, 375-385.
7. Qu, X.; Ren, J.; Riccelli, P. V.; Benight, A. S.; Chaires, J. B. Biochemistry 2003, 42, 11960-11967.
8. Sarcosin is a synonym for N-methylglycin. The term was introduced by Justus von Liebig, who first extracted this amino acid from the creatine of meat broth (gr. sarx = meat).
9. Brockmann, H.; Franck, B. Naturwissenschaften 1960, 47, 15.
10. Johnson, A. W.; Mauger, A. B. Biochem. J. 1959, 535-538.
11. Lifferth, A.; Bahner, I.; Lackner, H.; Schafer, M. Z. Naturforsch., B: Chem. Sci. 1999, 54, 681-691.
12. Lackner, H.; Bahner, I.; Shigematsu, N.; Pannell, L. K.; Mauger, A. B. J. Nat. Prod. 2000, 63, 352-6.
13. 1 was originally published as actinomycin HKI-0155. The new name is a proposal made by A. B. Mauger and H. Lackner in remembrance of the natural product chemist U. Gräfe (HKI Jena, Germany, † 2003), who discovered this compound. The new term is used in a recent review [see ref 1].
14. Lackner, H.; Hulsmann, H.; Heinze, S.; Simon, H.; Bar, H.; Zimmer, C.; Gräfe, U. J. Antibiot. 2000, 53, 84-87.
15. Brockmann, H.; Lackner, H. Chem. Ber. 1968, 101, 2231-2243.
16. Brockmann, H. Cancer Chemother. Rep. 1974, 58, 9-19.
17. The term A-configuration refers to the configuration of the single peptidolactone in acetone and includes, starting from MeVa1, trans-cis-cis-trans configurated peptide bonds. In chloroform the ring adopts an all-trans configuration, whereas in complete actinomycin molecules the A-configuration is favored in all solvents due to transannular hydrogen bonds [see ref 5].
18. Jones, G. H.; Keller, U. Drugs Pharm. Sci. 1997, 82, 335-361.
19. Keller, U.; Schauwecker, F. Prog. Nucleic Acid Res. Mol. Biol. 2001, 70, 233-289.
20. Pfennig, F.; Schauwecker, F.; Keller, U. J. Biol. Chem. 1999, 274, 12508-12516.
21. Jones, G. H. Antimicrob. Agents Chemother. 2000, 44, 1322-1327.
22. Brockmann, H.; Bohnsack, G.; Franck, B.; Grone, H.; Muxfeldt, H.; Suling, C. H. Angew. Chem. 1956, 68, 70-71.
23. Mauger, A. B.; Stuart, O. A. J. Antibiot. 1990, 43, 220-221.
24. Vaillancourt, F. H.; Yin, J.; Walsh, C. T. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 10111-10116.
25. Hausinger, R. P. Crit. Rev. Biochem. Mol. Biol. 2004, 39, 21-68.
26. Jain, S. C.; Sobell, H. M. J. Mol. Biol. 1972, 68, 1-20.
27. Gesheva, V. Eur. J. Soil Biol. 2002, 38, 85-88.
28. Grever, M. R.; Schepartz, S. A.; Chabner, B. A. Semin. Oncol. 1992, 19, 622-638.